Arexvy

BOULDER, Colo., July 28, 2026 Ambrosia Biosciences Inc. has strengthened its leadership team and scientific capabilities with the appointment...

LONDON, July 30, 2026 GSK has reported strong Q2 2026 financial results, driven by continued growth across its Specialty...

LONDON, United Kingdom, May 20, 2026 GSK has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved...

Real-World Evidence Strengthens Adult Prevention Impact February 17, 2026 | London, United Kingdom GSK has released new real-world effectiveness...

London, United Kingdom, January 26, 2026 — GSK announced that the European Commission (EC) has approved an expanded indication...